Amphiphilic Carbohydrate Polymers Hierarchical Micellar Clusters

Solution Overview

Problem

Current methods for formulating drugs with poor aqueous solubility, such as hydrophobic drugs, face challenges in achieving sufficient bioavailability due to inefficient solubilization and stability issues in micellar systems, often requiring high molar ratios of amphiphilic compounds to drugs and resulting in limited bioavailability across biological barriers.

Innovation Solution

The development of amphiphilic carbohydrate polymers that self-assemble into hierarchically organized micellar clusters, which transform into stable nanoparticles, allowing for higher molar polymer/drug ratios and enhanced drug encapsulation and transfer across biological barriers, particularly for hydrophobic drugs with poor aqueous solubility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If conventional block copolymers are used to solubilize hydrophobic drugs, then micellar structures are formed, but the molar amphiphile/drug ratios are excessively high (exceeding 10:1 and frequently extending to 1000:1) resulting in inefficient drug carrying capacity

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention divides the micellar structure into hierarchical levels: individual micelles self-assemble from amphiphilic block copolymer chains, and these micelles further aggregate to form micellar clusters. This segmentation creates a multi-level organization where the hydrophobic core volume is dramatically increased through cluster formation, enabling much higher drug carrying capacity without proportionally increasing the amphiphile/drug ratio

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention merges multiple individual micelles into larger micellar clusters through controlled aggregation. By combining the hydrophobic cores of multiple micelles while maintaining their individual structural integrity, the system creates a larger effective hydrophobic volume that can accommodate more drug molecules, thereby improving drug carrying capacity while reducing the required amphiphile/drug ratio

Inventive Principle:
Principle #5Merging (Combining)

2Quantity of substance

If the aggregation number of monomers is increased to yield larger particles and increase hydrophobic volume, then drug solubilization capacity is improved, but excessive aggregation leads to precipitation of the colloid forming molecules and the drug

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The invention segments the aggregation process into two distinct levels: first, individual micelles form with controlled aggregation numbers; second, these micelles aggregate into clusters. This segmentation allows the system to achieve large effective hydrophobic volume for drug solubilization while maintaining the stability of individual micellar units, preventing the uncontrolled aggregation that would lead to precipitation

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention introduces dynamic control over the aggregation process through parameters such as amphiphile concentration, temperature, and solvent conditions. By controlling the degree of micelle-micelle aggregation, the system can optimize the balance between achieving sufficient hydrophobic volume for drug solubilization and maintaining colloid stability to prevent precipitation

Inventive Principle:
Principle #15Dynamics

3Quantity of substance

If conventional micellar systems are used for hydrophobic drugs, then some solubilization is achieved, but bioavailability across biological barriers remains limited

Engineering Contradiction:
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention transitions from conventional single-level micellar structures to a hierarchical two-level structure where micelles aggregate into clusters. This dimensional change in structural organization creates a more complex architecture with larger effective hydrophobic volume and potentially different surface properties, enabling improved penetration across biological barriers and enhanced bioavailability

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly improves the bioavailability of hydrophobic drugs by increasing the drug transfer across biological barriers by an order of magnitude and achieving higher drug encapsulation levels compared to conventional block copolymers, with molar drug encapsulation ratios up to 1:67, enhancing the delivery of poorly soluble drugs.

Implementation Method 1

amphiphilic carbohydrate polymers are capable of self assembling to form micellar clusters in which the carbohydrate amphiphiles aggregate into hierarchically organised micellar clusters of individual aggregates

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

the combination of both polar and apolar segments in a molecule allows the manipulation of immiscible liquids

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 3

Micellar phases have been used to solubilise drugs in aqueous media

Methodology Applied
Scientific EffectSolubilization: Solvation

Data Source

PatentEP2051998B1Polymeric micellar clusters and their uses in formulating drugs
Publication Date: 2019.02.13
  • EP2051998B1 patent drawingFigure 1~2a
  • EP2051998B1 patent drawingFigure 2b~2c
  • EP2051998B1 patent drawingFigure 2d~3a

AI summary

Polymeric micellar clusters formed from amphiphilic carbohydrate polymers and their uses in formulating drugs is disclosed, and in particular the finding that amphiphilic carbohydrate polymers are capable of self assembling to form micellar clusters in which the carbohydrate amphiphiles aggregate into hierarchically organised micellar clusters of individual aggregates. The micellar clusters may be transformed into stable nanoparticles with drugs, especially hydrophobic drugs that have poor aqueous solubility, and may improve the transfer of hydrophobic drugs across biological barriers.